Cell Cycle Regulated Phosphorylation of the Telomere-Associated Protein TIN2

por Yang, Shuqun, Counter, Christopher M.
Publicado 2013

Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)

por Huang, Lu, Counter, Christopher M.
Publicado 2015

Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability

por Adhikari, Hema, Counter, Christopher M.
Publicado 2018

Signaling levels mold the RAS mutation tropism of urethane

por Li, Siqi, Counter, Christopher M
Publicado 2021

Non-canonical genomic driver mutations of urethane carcinogenesis

por Li, Siqi, Counter, Christopher M.
Publicado 2022

An ultra-sensitive method to detect mutations in human RAS templates

por Li, Siqi, Counter, Christopher M.
Publicado 2022

Breaking up is hard to do: RalA, mitochondrial fission and cancer

por Kashatus, David F., Counter, Christopher M.
Publicado 2011

Snm1B Interacts with PSF2

por Stringer, Jay R., Counter, Christopher M.
Publicado 2012

Capturing the primordial Kras mutation initiating urethane carcinogenesis

por Li, Siqi, MacAlpine, David M., Counter, Christopher M.
Publicado 2020

Decreased tumorigenesis in mice with a Kras point mutation at C118

por Huang, Lu, Carney, John, Cardona, Diana M., Counter, Christopher M.
Publicado 2014

Expression of transgenes enriched in rare codons is enhanced by the MAPK pathway

por Peterson, Jackson, Li, Siqi, Kaltenbrun, Erin, Erdogan, Ozgun, Counter, Christopher M.
Publicado 2020

Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer

por Pershing, Nicole L.K., Yang, Chi-Fu J., Xu, MengMeng, Counter, Christopher M.
Publicado 2016

Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice

por Weyandt, Jamie D., Carney, John M., Pavlisko, Elizabeth N., Xu, MengMeng, Counter, Christopher M.
Publicado 2016

Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity

por Adhikari, Hema, Kattan, Walaa E., Kumar, Shivesh, Zhou, Pei, Hancock, John F., Counter, Christopher M.
Publicado 2021

Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer

por Weyandt, Jamie D., Lampson, Benjamin L., Tang, Sherry, Mastrodomenico, Matthew, Cardona, Diana M., Counter, Christopher M.
Publicado 2015

Ral activation promotes melanomagenesis

por Zipfel, Patty A., Brady, Donita C., Kashatus, David F., Ancrile, Brooke D., Tyler, Douglas S., Counter, Christopher M.
Publicado 2010

RalA and RalBP1 regulate mitochondrial fission at mitosis

por Kashatus, David F., Lim, Kian-Huat, Brady, Donita C., Pershing, Nicole L.K., Cox, Adrienne D., Counter, Christopher M.
Publicado 2011

Creating Porcine Biomedical Models Through Recombineering

por Rogatcheva, Margarita M., Rund, Laurie A., Swanson, Kelly S., Marron, Brandy M., Beever, Jonathan E., Counter, Christopher M., Schook, Lawrence B.
Publicado 2004

Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance

por Ali, Moiez, Kaltenbrun, Erin, Anderson, Gray R., Stephens, Sarah Jo, Arena, Sabrina, Bardelli, Alberto, Counter, Christopher M., Wood, Kris C.
Publicado 2017

Distinct responses to rare codons in select Drosophila tissues

por Allen, Scott R, Stewart, Rebeccah K, Rogers, Michael, Ruiz, Ivan Jimenez, Cohen, Erez, Laederach, Alain, Counter, Christopher M, Sawyer, Jessica K, Fox, Donald T
Publicado 2022